| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.08 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.29 | 0.08 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.078 | 0.08 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.08 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.077 | 0.08 |